Neurotoxic Amyloidogenic Peptides Identified in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19
S. Islam, M. Charnley, G. Bindra, J. Ratcliffe, J. Zhou, R. Mezzenga, M. D. Hulett, K. Han, J. T. Berryman, N. P. Reynolds
The paper identifies amyloidogenic peptides in SARS-CoV-2 that are toxic to neuronal cells, suggesting they may contribute to neurological symptoms and long COVID.
bioRxiv · Nov 24, 2021 · PreprintBiochemistry